Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Photodynamic Therapy Market Size from 2025 to 2034?
There has been significant growth in the photodynamic therapy market size in the past few years. The market, which was valued at $1.45 billion in 2024, is projected to increase to $1.53 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include a rise in the aging population, an uptick in cancer incidence and skin disorders, escalating pollution levels, higher spending on healthcare, and an expansion in the number of healthcare establishments.
In the coming years, there is anticipated vigorous expansion in the market for photodynamic therapy, which is projected to reach $1.93 billion in 2029, flourishing at a compounded annual growth rate (CAGR) of 6.0%. The predicted increase during this period can be credited to factors such as expanding healthcare investment, coverage of photodynamic therapy by insurance, promising opportunities in developing economies, a surge in the adolescent and aged demographic, an escalated incidence of cancer and chronic disorders, and the advent of contagious diseases. The noteworthy trends for the forecasted tenure are the launching of portable devices for photodynamic therapy that aid in conducting dermatological PDT procedures at home, channeling funds into AI-powered PDT to better patient treatment, broadening the product spectrum in the realm of cosmetic treatments, ongoing funding for research and development, and striving to offer photoimmunotherapy devices besides augmenting the portfolio to incorporate photothermal therapy.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Photodynamic Therapy Market?
The surge in skin cancer incidences is propelling the photodynamic therapy market. Skin cancer happens to be the most prevalent type of cancer. Even though melanoma accounts for only about 1% of skin cancers, it’s responsible for a significant number of skin cancer fatalities. Photodynamic therapy (PDT) employs a combination of a photosensitizing drug and a high-intensity light source to eradicate cancer cells. In this process, a lotion containing a photosensitizing chemical is applied by the physician to the skin cancer as well as the nearby area. For instance, the American Cancer Society, a renowned US organization, stated in January 2024 that skin cancer is the most frequently observed cancer in the U.S., with melanoma accounting for 1% of the cases but leading to most skin cancer deaths. Furthermore, in 2024, an expected 100,640 fresh melanoma cases will be identified in the U.S., including approximately 59,170 men and 41,470 women. About 8,290 fatalities from melanoma are foreseen, with approximately 5,430 men and 2,860 women among them. Thus, the escalating prevalence of skin cancer is projected to boost the photodynamic therapy market in future years.
Which Key Market Segments Comprise the Photodynamic Therapy Market and Drive Its Revenue Growth?
The photodynamic therapy market covered in this report is segmented –
1) By Product: Drugs, Devices
2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications
3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users
Subsegments:
1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations
2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp
Which Areas Are Leading Regions in the Photodynamic Therapy Market Expansion Across the Globe?
North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in thePhotodynamic Therapy Market Over the Coming Years?
Industry participants in the photodynamic therapy market are increasingly directing their efforts towards clinical trials that integrate PDT with various drugs. For example, Kintara Therapeutics, a biotechnology firm based in the US, initiated a clinical trial for its REM-001 therapy aimed at cutaneous metastatic breast cancer in February 2024. The open-label study NCT05374915, which encompasses 15 patients suffering from cutaneous metastatic breast cancer (CMBC), tests the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The trial’s objective is to refine the study design in anticipation of a Phase 3 trial and to concentrate on the Best Overall Objective Response Rate (bORR) within the treatment fields over a span of 24 weeks. The primary endpoint includes the measure of entire and partial responses.
View the full report here:
https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report
How Is the Photodynamic Therapy Market Conceptually Defined?
Photodynamic therapy refers to a procedure that uses a light source and medication that is light-sensitive to eliminate aberrant cells. Some eye and skin disorders, as well as specific cancers, can be treated with it. Photodynamic therapy (PDT) is a two-stage treatment that combines light energy with a drug (photosensitizer) designed to destroy cancerous and precancerous cells after light activation.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model